US OptionsDetailed Quotes
MRK241220C88000
- 9.85
- 0.000.00%
15min DelayClose Dec 16 16:00 ET
0.00High0.00Low
9.85Open9.85Pre Close0 Volume0 Open Interest88.00Strike Price0.00Turnover0.00%IV-2.21%PremiumDec 20, 2024Expiry Date12.06Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma8.36Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Merck & Co Stock Discussion
Sign in to post a comment
$Esperion Therapeutics (ESPR.US)$ Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry:
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...
10
1
4
$Esperion Therapeutics (ESPR.US)$ $Esperion Therapeutics (ESPR.US)$ Esperion Therapeutics (ESPR) is a biotech company that focuses on developing and commercializing therapies to lower cholesterol, specifically offering the only FDA-approved statin alternatives: NEXLIZET and NEXLETOL for PRIMARY PREVENTION. These drugs are designed for individuals who are statin intolerant or cannot achieve adequate cholesterol lowering with statin...
+4
6
9
1
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...
+2
13
1
4
Columns These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over.
It's been a banner year for the stock market. However, not every stock has been a winner as some sectors performed better than others. Tech and utilities soared, while others like real estate and healthcare underperformed.
So what are the five worst performers on the Dow Jones Industrial Average list of blue chip stocks? Let's take a look.
1. Boeing (down 36.5%)
Boeing $Boeing (BA.US)$ has had a r...
So what are the five worst performers on the Dow Jones Industrial Average list of blue chip stocks? Let's take a look.
1. Boeing (down 36.5%)
Boeing $Boeing (BA.US)$ has had a r...
3
One day after we got an inflation data (CPI) that came in line with expectation, the market received a hotter-than-expected producer price index (PPI) reading for November.
This is probably why the market is retreating a little bit.
That said, I believe the Fed will still proceed with its expected 25 basis point rate cut next week because other inflation data over the past few months are showing that it is trending downwards.
$Vanguard S&P 500 ETF (VOO.US)$ $KraneShares CSI China Internet ETF (KWEB.US)$ $First Republic Bank (FRCB.US)$ $Crude Oil Futures(FEB5) (CLmain.US)$ $Goldman Sachs (GS.US)$ $Citigroup (C.US)$ $ChargePoint (CHPT.US)$ $LivePerson (LPSN.US)$ $Clover Health (CLOV.US)$ $Vanguard Growth ETF (VUG.US)$ $JD.com (JD.US)$ $Baidu (BIDU.US)$ $FuboTV (FUBO.US)$ $Merck & Co (MRK.US)$ $The Trade Desk (TTD.US)$
This is probably why the market is retreating a little bit.
That said, I believe the Fed will still proceed with its expected 25 basis point rate cut next week because other inflation data over the past few months are showing that it is trending downwards.
$Vanguard S&P 500 ETF (VOO.US)$ $KraneShares CSI China Internet ETF (KWEB.US)$ $First Republic Bank (FRCB.US)$ $Crude Oil Futures(FEB5) (CLmain.US)$ $Goldman Sachs (GS.US)$ $Citigroup (C.US)$ $ChargePoint (CHPT.US)$ $LivePerson (LPSN.US)$ $Clover Health (CLOV.US)$ $Vanguard Growth ETF (VUG.US)$ $JD.com (JD.US)$ $Baidu (BIDU.US)$ $FuboTV (FUBO.US)$ $Merck & Co (MRK.US)$ $The Trade Desk (TTD.US)$
From YouTube
8
Alot of times you would hear people say, roll down (csp) or roll up (covered call) their option contracts. Basically rolling your contract is cancel the first contract (cut loss) and open a new second contract. But the second contract must cover the loss of the first contract or minimum must break even or take a small loss.
On oct 10/24, open 2 x mrk contracts at 109.29c, strike at 105 and premium of 192 x 2 (35 dte). On nov 5/24, i closed 2 x contracts a...
On oct 10/24, open 2 x mrk contracts at 109.29c, strike at 105 and premium of 192 x 2 (35 dte). On nov 5/24, i closed 2 x contracts a...
6
$Merck & Co (MRK.US)$
Merck’s Investigational Zilovertamab Vedotin in Combination With R-CHP Demonstrates Complete Response Rate of 100% at 1.75 mg/kg Dose in Phase 2 Trial of Previously Untreated Patients With Diffuse Large B-Cell Lymphoma
Positive
100% complete response rate achieved at 1.75 mg/kg dose level
High overall response rate across all dosage groups (93.3-100%)
Strong 12-month duration of response at 93.5%
Successfully established recommended Phase 3 dose
Negative
58% of patients exp...
Merck’s Investigational Zilovertamab Vedotin in Combination With R-CHP Demonstrates Complete Response Rate of 100% at 1.75 mg/kg Dose in Phase 2 Trial of Previously Untreated Patients With Diffuse Large B-Cell Lymphoma
Positive
100% complete response rate achieved at 1.75 mg/kg dose level
High overall response rate across all dosage groups (93.3-100%)
Strong 12-month duration of response at 93.5%
Successfully established recommended Phase 3 dose
Negative
58% of patients exp...
No comment yet
Alwayslearning5 : LOL